KD Logo

Royalty Pharma plc [RPRX] Records 200-Day SMA of $28.36

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Royalty Pharma plc shares valued at $983,504 were sold by RIGGS RORY B on Jan 04 ’24. At $27.55 per share, RIGGS RORY B sold 35,702 shares. The insider’s holdings dropped to 20,099 shares worth approximately $0.54 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Also, RIGGS RORY B sold 199,098 shares, netting a total of over 5,532,276 in proceeds. Following the sale of shares at $27.79 each, the insider now holds 55,801 shares.

Before that, RIGGS RORY B had sold 235,200 shares from its account. In a trade valued at $6,707,081, the Director traded Royalty Pharma plc shares for $28.52 each. Upon closing the transaction, the insider’s holdings decreased to 235,200 shares, worth approximately $6.91 million.

As published in a research note from UBS on June 03, 2024, Royalty Pharma plc [RPRX] has been rated down from a Buy to a Neutral and the price target has been revised to $28. As of May 13, 2022, Scotiabank has initiated its “Sector outperform” rating for RPRX. Earlier on April 27, 2022, Goldman initiated its rating. Their recommendation was “a Buy” for RPRX stock.

Analyzing RPRX Stock Performance

During the last five days, there has been a surge of approximately 2.65%. Over the course of the year, Royalty Pharma plc shares have dropped approximately -3.56%. Shares of the company reached a 52-week high of $31.66 on 02/27/24 and a 52-week low of $26.10 on 05/30/24. A 50-day SMA is recorded $28.07, while a 200-day SMA reached $28.36. Nevertheless, trading volume fell to 1.7 million shares from 2.16 million shares the previous day.

Support And Resistance Levels for Royalty Pharma plc (RPRX)

According to the 24-hour chart, there is a support level at 26.87, which, if violated, would cause prices to drop to 26.65. In the upper region, resistance lies at 27.32. The next price resistance is at 27.55. RSI (Relative Strength Index) is 45.01 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.07, which suggests the price will decrease in the coming days. Percent R is at 42.90%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular